Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

BRCC3 inhibits cell differentiation. 1 / 1

| 1

➶

reach

"Inhibition of beta-catenin reversed BRCC3 siRNA induced osteogenic differentiation To test the role of beta-catenin in BRCC3 siRNA actions, cells were treated with XAV939 to inhibit the activation of beta-catenin signaling."

30834083

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...